Why Amicus Therapeutics Stock Is Rising Today
Shares of rare-disease specialist Amicus Therapeutics (NASDAQ: FOLD) are marching higher today. Specifically, the drugmaker's stock is up by 10% as of 12:45 p.m. EST.
What's driving this double-digit rally today? The biotech's shares are jumping in response to a noteworthy upgrade from Cantor Fitzgerald's analyst Eliana Merle. The big-ticket item is that Merle's forward-looking price target of $20 per share implies a whopping 124% upside potential -- that is, relative to where the biotech's stock closed on Monday.
Image source: Getty Images.
Source Fool.com
